vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是COLLEGIUM PHARMACEUTICAL, INC的1.6倍（$324.4M vs $205.4M），COLLEGIUM PHARMACEUTICAL, INC净利率更高（8.3% vs 5.7%，领先2.5%），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs 10.4%），COLLEGIUM PHARMACEUTICAL, INC自由现金流更多（$122.4M vs $-13.3M），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs 9.5%）
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
COLL vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.6倍
$205.4M
营收增速更快
COLL
高出2.5%
10.4%
净利率更高
COLL
高出2.5%
5.7%
自由现金流更多
COLL
多$135.6M
$-13.3M
两年增速更快
COLL
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $324.4M |
| 净利润 | $17.0M | $18.6M |
| 毛利率 | 62.5% | 53.3% |
| 营业利润率 | 29.6% | 6.3% |
| 净利率 | 8.3% | 5.7% |
| 营收同比 | 12.9% | 10.4% |
| 净利润同比 | 35.3% | 50.4% |
| 每股收益（稀释后） | $0.48 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COLLRVLV
| Q4 25 | $205.4M | $324.4M | ||
| Q3 25 | $209.4M | $295.6M | ||
| Q2 25 | $188.0M | $309.0M | ||
| Q1 25 | $177.8M | $296.7M | ||
| Q4 24 | $181.9M | $293.7M | ||
| Q3 24 | $159.3M | $283.1M | ||
| Q2 24 | $145.3M | $282.5M | ||
| Q1 24 | $144.9M | $270.6M |
净利润COLLRVLV
| Q4 25 | $17.0M | $18.6M | ||
| Q3 25 | $31.5M | $21.2M | ||
| Q2 25 | $12.0M | $10.2M | ||
| Q1 25 | $2.4M | $11.8M | ||
| Q4 24 | $12.5M | $12.3M | ||
| Q3 24 | $9.3M | $11.0M | ||
| Q2 24 | $19.6M | $15.4M | ||
| Q1 24 | $27.7M | $10.9M |
毛利率COLLRVLV
| Q4 25 | 62.5% | 53.3% | ||
| Q3 25 | 61.7% | 54.6% | ||
| Q2 25 | 57.7% | 54.1% | ||
| Q1 25 | 54.8% | 52.0% | ||
| Q4 24 | 54.0% | 52.5% | ||
| Q3 24 | 60.8% | 51.2% | ||
| Q2 24 | 62.5% | 54.0% | ||
| Q1 24 | 63.1% | 52.3% |
营业利润率COLLRVLV
| Q4 25 | 29.6% | 6.3% | ||
| Q3 25 | 29.7% | 7.1% | ||
| Q2 25 | 18.7% | 5.8% | ||
| Q1 25 | 12.2% | 5.0% | ||
| Q4 24 | 20.9% | 3.9% | ||
| Q3 24 | 21.9% | 5.0% | ||
| Q2 24 | 32.7% | 5.8% | ||
| Q1 24 | 34.1% | 3.4% |
净利率COLLRVLV
| Q4 25 | 8.3% | 5.7% | ||
| Q3 25 | 15.0% | 7.2% | ||
| Q2 25 | 6.4% | 3.3% | ||
| Q1 25 | 1.4% | 4.0% | ||
| Q4 24 | 6.9% | 4.2% | ||
| Q3 24 | 5.9% | 3.9% | ||
| Q2 24 | 13.5% | 5.4% | ||
| Q1 24 | 19.1% | 4.0% |
每股收益（稀释后）COLLRVLV
| Q4 25 | $0.48 | $0.27 | ||
| Q3 25 | $0.84 | $0.29 | ||
| Q2 25 | $0.34 | $0.14 | ||
| Q1 25 | $0.07 | $0.16 | ||
| Q4 24 | $0.36 | $0.18 | ||
| Q3 24 | $0.27 | $0.15 | ||
| Q2 24 | $0.52 | $0.21 | ||
| Q1 24 | $0.71 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $386.7M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $301.7M | $512.5M |
| 总资产 | $1.7B | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COLLRVLV
| Q4 25 | $386.7M | $292.3M | ||
| Q3 25 | $285.9M | $315.4M | ||
| Q2 25 | $222.2M | $310.7M | ||
| Q1 25 | $197.8M | $300.8M | ||
| Q4 24 | $162.8M | $256.6M | ||
| Q3 24 | $120.0M | $252.8M | ||
| Q2 24 | $271.6M | $244.7M | ||
| Q1 24 | $318.0M | $273.4M |
股东权益COLLRVLV
| Q4 25 | $301.7M | $512.5M | ||
| Q3 25 | $274.8M | $490.2M | ||
| Q2 25 | $232.2M | $468.6M | ||
| Q1 25 | $234.4M | $453.4M | ||
| Q4 24 | $228.8M | $437.8M | ||
| Q3 24 | $234.3M | $420.8M | ||
| Q2 24 | $216.6M | $405.8M | ||
| Q1 24 | $222.2M | $389.9M |
总资产COLLRVLV
| Q4 25 | $1.7B | $765.0M | ||
| Q3 25 | $1.6B | $751.3M | ||
| Q2 25 | $1.6B | $722.9M | ||
| Q1 25 | $1.6B | $713.9M | ||
| Q4 24 | $1.7B | $665.5M | ||
| Q3 24 | $1.6B | $670.9M | ||
| Q2 24 | $1.1B | $657.8M | ||
| Q1 24 | $1.1B | $650.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.0M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $122.4M | $-13.3M |
| 自由现金流率自由现金流/营收 | 59.6% | -4.1% |
| 资本支出强度资本支出/营收 | 0.3% | 1.0% |
| 现金转化率经营现金流/净利润 | 7.25× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $327.6M | $48.0M |
8季度趋势，按日历期对齐
经营现金流COLLRVLV
| Q4 25 | $123.0M | $-10.2M | ||
| Q3 25 | $78.4M | $11.8M | ||
| Q2 25 | $72.4M | $12.6M | ||
| Q1 25 | $55.4M | $45.1M | ||
| Q4 24 | $84.6M | $3.9M | ||
| Q3 24 | $-9.0M | $9.1M | ||
| Q2 24 | $67.4M | $-24.7M | ||
| Q1 24 | $61.9M | $38.4M |
自由现金流COLLRVLV
| Q4 25 | $122.4M | $-13.3M | ||
| Q3 25 | $78.3M | $7.5M | ||
| Q2 25 | $72.4M | $10.4M | ||
| Q1 25 | $54.6M | $43.4M | ||
| Q4 24 | $84.1M | $2.1M | ||
| Q3 24 | $-9.2M | $8.0M | ||
| Q2 24 | $67.1M | $-25.7M | ||
| Q1 24 | $61.4M | $36.7M |
自由现金流率COLLRVLV
| Q4 25 | 59.6% | -4.1% | ||
| Q3 25 | 37.4% | 2.5% | ||
| Q2 25 | 38.5% | 3.4% | ||
| Q1 25 | 30.7% | 14.6% | ||
| Q4 24 | 46.2% | 0.7% | ||
| Q3 24 | -5.8% | 2.8% | ||
| Q2 24 | 46.2% | -9.1% | ||
| Q1 24 | 42.3% | 13.5% |
资本支出强度COLLRVLV
| Q4 25 | 0.3% | 1.0% | ||
| Q3 25 | 0.1% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.3% | 0.6% | ||
| Q3 24 | 0.2% | 0.4% | ||
| Q2 24 | 0.2% | 0.4% | ||
| Q1 24 | 0.4% | 0.6% |
现金转化率COLLRVLV
| Q4 25 | 7.25× | -0.55× | ||
| Q3 25 | 2.49× | 0.56× | ||
| Q2 25 | 6.05× | 1.24× | ||
| Q1 25 | 22.92× | 3.82× | ||
| Q4 24 | 6.75× | 0.32× | ||
| Q3 24 | -0.96× | 0.83× | ||
| Q2 24 | 3.44× | -1.60× | ||
| Q1 24 | 2.23× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COLL
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
